<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03945123</url>
  </required_header>
  <id_info>
    <org_study_id>RIVER</org_study_id>
    <nct_id>NCT03945123</nct_id>
  </id_info>
  <brief_title>Effects of Red Ginseng on Liver Function</brief_title>
  <official_title>Effect of Korea Red Ginseng on Non-alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chuncheon Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chuncheon Sacred Heart Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Korea Red Ginseng (KRG) has effect on liver function
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Korea Red Ginseng (KRG) has been known as a natural product with anti-inflammatory effect in
      liver disease. Gut microbiota plays an important roles in the pathophysiology of nonalcoholic
      statohepatitis (NASH). We evaluated the effect of KRG on the pathophysiology of NASH
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver enzyme</measure>
    <time_frame>1year</time_frame>
    <description>Decrease liver enzyme level</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Liver Dysfunction</condition>
  <arm_group>
    <arm_group_label>Ginseng trial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>compare experimental group to controlled group</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Red ginseng</intervention_name>
    <description>Red ginseng tablet 120g</description>
    <arm_group_label>Ginseng trial</arm_group_label>
    <other_name>Red ginseng tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AST or ALT level &gt; 50 IU/L

        Exclusion Criteria:

          -  Viral hepatitis

          -  Alcoholic hepatitis

          -  Autoimmune hepatitis

          -  Pancreatitis

          -  Hemochromatosis

          -  Wilson's disease

          -  Drug induced liver injury

          -  Cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>37 Years</minimum_age>
    <maximum_age>63 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ki Tae Suk, PhD.Md.</last_name>
    <role>Study Chair</role>
    <affiliation>Chuncheon Sacred Heart Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Seok, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chuncheon Sacred Heart Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ChuncheonSHH</name>
      <address>
        <city>Chuncheon</city>
        <state>Kangwon</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>May 7, 2019</last_update_submitted>
  <last_update_submitted_qc>May 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chuncheon Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Ki Tae Suk</investigator_full_name>
    <investigator_title>Proffesor</investigator_title>
  </responsible_party>
  <keyword>ginseng</keyword>
  <keyword>Liver</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not yet</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

